These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10669448)

  • 21. Molecular markers. Tissue cork borer.
    Peters R; Sikorski R
    Science; 1998 Aug; 281(5380):1163. PubMed ID: 9735032
    [No Abstract]   [Full Text] [Related]  

  • 22. Beyond hematoxylin and eosin--the role of immunohistochemistry in surgical pathology.
    Jaffer S; Bleiweiss IJ
    Cancer Invest; 2004; 22(3):445-65. PubMed ID: 15493365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncotype DX test on unequivocally HER2-positive cases: potential for harm.
    Bhargava R; Dabbs DJ
    J Clin Oncol; 2012 Feb; 30(5):570-1. PubMed ID: 22231038
    [No Abstract]   [Full Text] [Related]  

  • 24. Relevance of micrometastases detected by reverse transcriptase-polymerase chain reaction for melanoma recurrence: systematic review and meta-analysis.
    da Silva AM; de Oliveira Filho RS; Ferreira LM; Saconato H
    Sao Paulo Med J; 2003 Jan; 121(1):24-7. PubMed ID: 12751340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Tests for Estrogen Receptor-Positive Breast Cancer: Need for Global Consideration and Further Evolution.
    Kim JY; Kim SI; Paik S
    JAMA Oncol; 2016 Feb; 2(2):180-2. PubMed ID: 26633601
    [No Abstract]   [Full Text] [Related]  

  • 26. Circulating melanoma-associated markers detected by RT-PCR in patients with classic Kaposi's sarcoma.
    Palmieri G; Ascierto PA; Satriano SM; Strazzullo M; Apice G; Castello G
    Ann Oncol; 2000 May; 11(5):635-6. PubMed ID: 10907962
    [No Abstract]   [Full Text] [Related]  

  • 27. Pan-Cancer Biomarkers: Changing the Landscape of Molecular Testing.
    Yao J; Arcila ME; Ladanyi M; Hechtman JF
    Arch Pathol Lab Med; 2021 Jun; 145(6):692-698. PubMed ID: 33373449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR.
    Raynor MP; Stephenson SA; Pittman KB; Walsh DC; Henderson MA; Dobrovic A
    J Hematol Oncol; 2009 Jun; 2():24. PubMed ID: 19500345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection of markers to predict tumour response or survival: description of a novel approach.
    McLeod HL; Murray GI; Mollison J; McKay J; Cassidy J
    Eur J Cancer; 1999 Nov; 35(12):1650-2. PubMed ID: 10674008
    [No Abstract]   [Full Text] [Related]  

  • 30. New diagnostic techniques in staging in the surgical treatment of cutaneous malignant melanoma.
    Cobben DC; Koopal S; Tiebosch AT; Jager PL; Elsinga PH; Wobbes T; Hoekstra HJ
    Eur J Surg Oncol; 2002 Nov; 28(7):692-700. PubMed ID: 12431464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC.
    Vilmar A; Garcia-Foncillas J; Huarriz M; Santoni-Rugiu E; Sorensen JB
    Lung Cancer; 2012 Mar; 75(3):306-12. PubMed ID: 21996087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New prognostic factors in melanoma: mRNA tumour markers.
    Keilholz U
    Eur J Cancer; 1998 Jul; 34 Suppl 3():S37-41. PubMed ID: 9849408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The clinical prospects for the study of epidermal growth factor receptors in human tumors].
    Kushpinskiĭ NE; Gershteĭn ES
    Klin Lab Diagn; 1996; (1):9-12. PubMed ID: 8775779
    [No Abstract]   [Full Text] [Related]  

  • 34. Soluble Fas and cancer.
    Owen-Schaub L
    Clin Cancer Res; 2001 May; 7(5):1108-9. PubMed ID: 11350870
    [No Abstract]   [Full Text] [Related]  

  • 35. Discover, Develop & Validate--Advance and Prospect of Tumor Biomarkers.
    Zhou Q; Hu HG; Hou L
    Clin Lab; 2015; 61(11):1589-99. PubMed ID: 26731982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the clinical significance of tumor markers in common neoplasms.
    Beketic-Oreskovic L; Maric P; Ozretic P; Oreskovic D; Ajdukovic M; Levanat S
    Front Biosci (Elite Ed); 2012 Jun; 4(7):2558-78. PubMed ID: 22652661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment.
    Lankiewicz S; Rivero BG; Bócher O
    Mol Biotechnol; 2006 Sep; 34(1):15-27. PubMed ID: 16943567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunophenotypic and genotypic analysis of a case of primary peripheral primitive neuroectodermal tumour (pPNET) of the urinary bladder.
    Colecchia M; Dagrada GP; Poliani PL; Pilotti S
    Histopathology; 2002 Jan; 40(1):108-9. PubMed ID: 11903609
    [No Abstract]   [Full Text] [Related]  

  • 39. Further evidence for expression and function of the VEGF-C/VEGFR-3 axis in cancer cells.
    Su JL; Chen PS; Chien MH; Chen PB; Chen YH; Lai CC; Hung MC; Kuo ML
    Cancer Cell; 2008 Jun; 13(6):557-60. PubMed ID: 18538739
    [No Abstract]   [Full Text] [Related]  

  • 40. Proteomics: from signature to protein identification.
    Tuma RS
    J Natl Cancer Inst; 2004 Jun; 96(11):817. PubMed ID: 15173259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.